Catalent, Inc. (CTLT) Social Stream
Catalent Inc (CTLT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CTLT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 10 | $172 | $132 | $156.6 | $110.83 | 41.3% |
| 2021-11-15 | 10 | $172 | $132 | $156.8 | $110.83 | 41.48% |
| 2021-12-01 | 10 | $172 | $132 | $157.5 | $110.83 | 42.11% |
| 2022-01-05 | 10 | $172 | $132 | $157.727 | $110.83 | 42.31% |
| 2022-02-01 | 11 | $172 | $132 | $157.727 | $110.83 | 42.31% |
| 2022-02-02 | 11 | $168 | $145 | $159.9 | $110.83 | 44.28% |
| 2022-02-03 | 11 | $167 | $129 | $150.6 | $110.83 | 35.88% |
| 2022-03-11 | 11 | $160 | $129 | $149.3 | $110.83 | 34.71% |
The Trend in the Analyst Price Target
CTLT's average price target has moved up $57.5 over the prior 20 months.
CTLT reports an average of 37.1% for its upside potential over the past 128 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 10 | 172 | 132 | 156.6 | 136.01 | 15.14% |
| 2021-12-01 | 9 | 172 | 132 | 157.5 | 127.31 | 23.71% |
| 2021-12-01 | 10 | 172 | 132 | 157.5 | 127.31 | 23.71% |
| 2022-02-02 | 11 | 167 | 140 | 154.1 | 106.19 | 45.12% |
| 2022-02-02 | 11 | 168 | 145 | 159.9 | 106.19 | 50.58% |
CTLT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.32 | 8 | 2 | 1 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
CTLT's average broker recommendation rating improved by 0 over the prior 28 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CTLT as an investment opportunity.
- Catalent Inc's average analyst price target is higher than 839.86% of all US stocks.
- CTLT has a greater upside potential (average analyst target price relative to current price) than 180.41% of Pharmaceutical Products stocks.
- Catalent Inc's variance in analysts' estimates is lower than -81.72% of Pharmaceutical Products stocks.
- CTLT has a higher number of analysts covering the stock than 817.53% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, BMY, BMRN, and BHC are the three stocks most similar to Catalent Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding CTLT using the data that counts. Try POWR Ratings for free.